Quadrivalent Human Papillomavirus (Types 6, 11, 16, 18) Recombinant Vaccine (Gardasil®): A Review of Its Use in the Prevention of Premalignant Anogenital Lesions, Cervical and Anal Cancers, and Genital Warts

2014/07/01 by Paul L. McCormack · 26 citations
Medicine · Immunology and Microbiology · #Cervical Cancer and HPV Research #Hepatitis B Virus Studies #Immunotherapy and Immune Responses

paper · doi:10.1007/s40265-014-0255-z

Cited by

• Development of HPV nanovaccine candidate based on IL-15-E7 fusion protein encapsulated in silk-fibroin nanoparticles
• Early direct and indirect impact of quadrivalent HPV (4HPV) vaccine on genital warts: a systematic review. [europepmc]
• Changing paradigms in the systemic treatment of advanced cervical cancer. [europepmc]
• Reprogramming energy metabolism and inducing angiogenesis: co-expression of monocarboxylate transporters with VEGF family members in cervical adenocarcinomas. [europepmc]
• The incidence, clearance and persistence of non-cervical human papillomavirus infections: a systematic review of the literature. [europepmc]
• Severe somatoform and dysautonomic syndromes after HPV vaccination: case series and review of literature. [europepmc]
• Expanded strain coverage for a highly successful public health tool: Prophylactic 9-valent human papillomavirus vaccine. [europepmc]
• Crystal Structures of Two Immune Complexes Identify Determinants for Viral Infectivity and Type-Specific Neutralization of Human Papillomavirus. [europepmc]
• Rational design of a triple-type human papillomavirus vaccine by compromising viral-type specificity. [europepmc]
• The Underlying Mechanism of 3-Hydroxyphthalic Anhydride-Modified Bovine Beta-Lactoglobulin to Block Human Papillomavirus Entry Into the Host Cell. [europepmc]
• Neutralization sites of human papillomavirus-6 relate to virus attachment and entry phase in viral infection. [europepmc]
• Human papillomavirus (HPV) subtypes and their relationships with cervical smear results in cervical cancer screening: a community-based study from the central Anatolia region of Turkey. [europepmc]
• Use of peripheral blood transcriptomic biomarkers to distinguish high-grade cervical squamous intraepithelial lesions from low-grade lesions. [europepmc]
• Gender Differences in Knowledge and Attitude towards HPV and HPV Vaccine among College Students in Wenzhou, China. [europepmc]
• Cancer vaccines: past, present and future; a review article. [europepmc]
• Prophylactic and Therapeutic HPV Vaccines: Current Scenario and Perspectives. [europepmc]
• Prophylactic Human Papillomavirus Vaccination: From the Origin to the Current State. [europepmc]
• Feminized vaccine? Parents' attitudes toward HPV vaccination of adolescents in Poland: A representative study. [europepmc]
• Preferential Expansion of HPV16 E1-Specific T Cells from Healthy Donors' PBMCs after Ex Vivo Immunization with an E1E2E6E7 Fusion Antigen. [europepmc]
• Current status and future directions for the development of human papillomavirus vaccines. [europepmc]
• Primary Prevention in Cervical Cancer-Current Status and Way Forward. [europepmc]
• Human Papillomavirus-Related Cancer Vaccine Strategies. [europepmc]
• Prevalence of Human Papillomavirus and Genotype Distribution in Chinese Men: A Systematic Review and Meta-Analysis. [europepmc]
• Advances in the Prevention of Cervical Cancer by Anti-Human Papillomavirus Agents. [europepmc]
• AS04 drives superior cross-protective antibody response by increased NOTCH signaling of dendritic cells and proliferation of memory B cells. [europepmc]
• Preclinical Assessment of a New Virus-like Particle-Based Quadrivalent Human Papillomavirus Vaccine in Animal Models. [europepmc]